IN2014DN03464A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN03464A IN2014DN03464A IN3464DEN2014A IN2014DN03464A IN 2014DN03464 A IN2014DN03464 A IN 2014DN03464A IN 3464DEN2014 A IN3464DEN2014 A IN 3464DEN2014A IN 2014DN03464 A IN2014DN03464 A IN 2014DN03464A
- Authority
- IN
- India
- Prior art keywords
- providing neuroprotection
- stroke
- mirna
- administering
- variant
- Prior art date
Links
- 230000004112 neuroprotection Effects 0.000 abstract 2
- 208000032382 Ischaemic stroke Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 108091070501 miRNA Proteins 0.000 abstract 1
- 239000002679 microRNA Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161555152P | 2011-11-03 | 2011-11-03 | |
| PCT/US2012/063604 WO2013067531A2 (fr) | 2011-11-03 | 2012-11-05 | Méthodes d'utilisation de micro-arn 195 pour la neuroprotection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN03464A true IN2014DN03464A (fr) | 2015-06-05 |
Family
ID=48193054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3464DEN2014 IN2014DN03464A (fr) | 2011-11-03 | 2012-11-05 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9315812B2 (fr) |
| EP (1) | EP2773381B1 (fr) |
| JP (1) | JP5888572B2 (fr) |
| CN (1) | CN104080910A (fr) |
| IN (1) | IN2014DN03464A (fr) |
| TW (1) | TWI462741B (fr) |
| WO (1) | WO2013067531A2 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2916989A1 (fr) * | 2013-06-28 | 2014-12-31 | London Health Sciences Centre Research Inc. | Inhibition du micro-arn pour le traitement de la septicemie |
| CN106474549B (zh) | 2016-11-21 | 2019-05-03 | 南通大学 | MicroRNA基因介导的新型组织工程化神经的构建及其在修复神经缺损的应用 |
| WO2018111784A1 (fr) * | 2016-12-14 | 2018-06-21 | China Medical University | Compositions de micro-arn 195 et leur utilisation thérapeutique dans des maladies oculaires |
| EP4100021A4 (fr) * | 2020-02-03 | 2023-11-15 | Rutgers, the State University of New Jersey | Compositions de micro-arn-7 destinées à favoriser la récupération fonctionnelle à la suite d'un traumatisme médullaire et leurs procédés d'utilisation |
| WO2022033529A1 (fr) * | 2020-08-12 | 2022-02-17 | 洪明奇 | Utilisation d'un antagoniste de sema3d dans la prévention ou le traitement de maladies neurodégénératives et prolongeant la durée de vie |
| CN113599540B (zh) * | 2021-05-27 | 2023-05-23 | 山西医科大学 | miRNA-195-5p在制备抑制或降低麦芽酚铝所致神经细胞损伤的试剂中的应用 |
| CN113308535A (zh) * | 2021-06-11 | 2021-08-27 | 中国人民解放军空军军医大学 | 一种基于血清外泌体miRNA的PD诊断及分期试剂盒 |
| CN116590403B (zh) * | 2023-05-17 | 2024-11-22 | 华中科技大学同济医学院附属同济医院 | 血浆外泌体microRNA novel-3及其拮抗剂和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| EP2530157B1 (fr) | 2003-07-31 | 2016-09-28 | Regulus Therapeutics Inc. | Composés oligomères et compositions à utiliser dans la modulation de miARNs |
| EP2295604B1 (fr) * | 2004-02-09 | 2015-04-08 | Thomas Jefferson University | Diagnostic et traitement de cancers à l'aide de microARN présent dans ou au voisinage de caractéristiques chromosomiques associées aux cancers |
| US20100298407A1 (en) * | 2007-01-17 | 2010-11-25 | The Johns Hopkins University | Compositions and methods featuring micronas for treating neoplasia |
| CA2705325C (fr) * | 2007-11-09 | 2016-11-01 | The Board Of Regents Of The University Of Texas System | Micro-arn de la famille mir-15 modulant la survie de cardiomyocytes et la reparation cardiaque |
| US20110117111A1 (en) * | 2008-03-26 | 2011-05-19 | Johns Hopkins University | Microrna-based diagnostic testing and therapies for inflammatory bowel disease and related diseases |
| EP2112235A1 (fr) | 2008-04-24 | 2009-10-28 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Compositions et procédés pour le profilage de l'expression de microARN du carcinome du nasopharynx |
| EP2239675A1 (fr) * | 2009-04-07 | 2010-10-13 | BIOCRATES Life Sciences AG | Procédé pour le diagnostic in vitro d'une maladie complexe |
| WO2010151640A2 (fr) * | 2009-06-24 | 2010-12-29 | Board Of Regents Of The University Of Nebraska | Compositions et procédés pour le diagnostic et le traitement de troubles inflammatoires et de maladie fibreuse |
| US8354520B2 (en) * | 2009-12-10 | 2013-01-15 | Kaohsiung Medical University | Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug |
-
2012
- 2012-11-05 IN IN3464DEN2014 patent/IN2014DN03464A/en unknown
- 2012-11-05 US US14/354,928 patent/US9315812B2/en not_active Expired - Fee Related
- 2012-11-05 EP EP12845133.3A patent/EP2773381B1/fr active Active
- 2012-11-05 CN CN201280053577.8A patent/CN104080910A/zh active Pending
- 2012-11-05 WO PCT/US2012/063604 patent/WO2013067531A2/fr not_active Ceased
- 2012-11-05 TW TW101141016A patent/TWI462741B/zh not_active IP Right Cessation
- 2012-11-05 JP JP2014540189A patent/JP5888572B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20140294943A1 (en) | 2014-10-02 |
| WO2013067531A3 (fr) | 2014-07-03 |
| JP2014533248A (ja) | 2014-12-11 |
| JP5888572B2 (ja) | 2016-03-22 |
| EP2773381A4 (fr) | 2015-07-08 |
| EP2773381A2 (fr) | 2014-09-10 |
| CN104080910A (zh) | 2014-10-01 |
| TWI462741B (zh) | 2014-12-01 |
| TW201322987A (zh) | 2013-06-16 |
| WO2013067531A2 (fr) | 2013-05-10 |
| EP2773381B1 (fr) | 2020-06-03 |
| US9315812B2 (en) | 2016-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN03464A (fr) | ||
| MX2019011905A (es) | Nuevas composiciones para el tratamiento de la esclerosis lateral amiotrofica. | |
| EP2757887A4 (fr) | Composés pyrrolopyridinones et méthodes de traitement du vih | |
| MX364495B (es) | Composición para usarse en el tratamiento de enfermedades oculares relacionadas con ácidos nucleicos. | |
| MX2013004570A (es) | Mezclas fungicidas de penflufen. | |
| SMT202100325T1 (it) | Metodi e composizioni per l’inibizione specifica della glicolato ossidasi (hao1) mediante rna a doppio filamento | |
| IN2012MU03723A (fr) | ||
| PL2763527T3 (pl) | Sposób obróbki grzybobójczej odpornych szczepów przy użyciu jednego lub więcej olejków eterycznych | |
| EP2677068A4 (fr) | Procédé de traitement de surface d'un élément métallique et élément métallique ainsi obtenu | |
| ZA201306990B (en) | Methods and compositions for treating, reducing, or preventing damage to the nervous system of animals | |
| PL2997173T3 (pl) | Sposób wytwarzania stali powleczonej cynkiem do utwardzania w procesie tłoczenia na gorąco | |
| MX2014010433A (es) | Nueva forma cristalina de sulfato de sitagliptina. | |
| EP2758780A4 (fr) | Méthode de traitement de la sclérose en plaques | |
| IN2015DN02292A (fr) | ||
| ZA201404327B (en) | Composition comprising block cocondensates of propylfunctional alkaline siliconates and silicates, and method for the production thereof | |
| IN2014DN08777A (fr) | ||
| EP2739332A4 (fr) | Obturateur/piston pour carpules d'ensemble seringue-carpule | |
| MX343968B (es) | Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus. | |
| ZA201408975B (en) | Method of treating scedosporium spp. infection | |
| MX2015003034A (es) | Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso. | |
| HUE038149T2 (hu) | Eljárás acél kezelésére | |
| PT2694065T (pt) | Placas de assentamento melhoradas | |
| PL2768527T3 (pl) | Wieloważna szczepionka przeciw CBV do zapobiegania lub leczenia cukrzycy typu 1 | |
| IN2013CH05865A (fr) | ||
| PT2678015E (pt) | Utilização de nifuratel para tratar infecções por espécies de clostridium |